57 results
Type of content
News Remove News filter
-
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2016 (corrected)
CHMP, Last updated: 21/09/2016Ivabradine Zentiva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-29 May 2019
CHMP, Last updated: 29/05/2019Ambrisentan Zentiva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2019
CHMP, Last updated: 20/09/2019Bavencio, Benlysta, Docetaxel Zentiva, Dupixent, Lucentis, Remsima … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 May 2017
CHMP, Last updated: 19/05/2017Emtricitabine / Tenofovir disoproxil Zentiva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2015
CHMP, Last updated: 26/06/2015Duloxetine Zentiva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 May 2015
CHMP, Last updated: 22/05/2015Pregabalin Zentiva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 April 2015
CHMP, Last updated: 24/04/2015Aripiprazole Zentiva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2016
CHMP, Last updated: 22/07/2016Tenofovir disoproxil Zentiva … -
List item
Press release: PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel
PRAC, Last updated: 09/06/2017Docetaxel Teva: EPAR Docetaxel Zentiva (previously Docetaxel Winthrop … Taxotere: EPAR Docetaxel Zentiva (previously Docetaxel Winthrop … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014
CHMP, Last updated: 21/11/2014Sevelamer carbonate Zentiva … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 January 2020
CHMP, Last updated: 31/01/2020bempedoic acid / ezetimibe) for the treatment of primary … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2013
CHMP, Last updated: 28/06/2013Irbesartan Zentiva INN irbesartan Marketing-authorisation … co-administer Irbesartan Zentiva with aliskiren-containing … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2016
CHMP, Last updated: 16/12/2016Pregabalin Zentiva k.s … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2013
PRAC, Last updated: 17/05/2013Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide … Irbesartan Teva: EPAR Irbesartan Zentiva (previously Irbesartan Winthrop … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 October 2011
CHMP, Last updated: 21/10/2011Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide … Irbesartan Teva: EPAR Irbesartan Zentiva (previously Irbesartan Winthrop … -
List item
Press release: European Medicines Agency concludes that benefit-risk balance of angiotensin-II-receptor antagonists remains positive
CHMP, Last updated: 20/10/2011Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide … Irbesartan Teva: EPAR Irbesartan Zentiva (previously Irbesartan Winthrop … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 15-18 February 2010
CHMP, Last updated: 19/02/2010treatment of colesevelam with ezetimibe, with or without a statin … treatment of colesevelam with ezetimibe, with or without a statin … -
List item
Press release: European Medicines Agency recommendation on use of angiotensin-II-receptor antagonists during pregnancy
Last updated: 24/04/2008Imprida: EPAR Irbesartan Zentiva (previously Irbesartan Winthrop … -
List item
Press release: European Medicines Agency confirms recommendation to suspend Tredaptive, Pelzont and Trevaclyn
CHMP, Last updated: 18/01/2013or simvastatin 40 mg plus ezetimibe 10 mg to achieve a total … or simvastatin 40 mg plus ezetimibe 10 mg to achieve a total … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 February 2012
CHMP, Last updated: 17/02/2012application/pdf Riluzole Zentiva riluzole Aventis Pharma S.A … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,27-30 May 2008
CHMP, Last updated: 02/06/20083% gel, (nimesulide) from Zentiva A.S., indicated for the symptomatic … 3% gel, (nimesulide) from Zentiva A.S., indicated for the symptomatic … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,18-21 February 2008
CHMP, Last updated: 21/02/20083% gel, (nimesulide) from Zentiva A.S., recommending the refusal … -
List item
News: EMA 2017 annual report published
Last updated: 02/05/2018 -
List item
Press release: European Medicines Agency publishes 2012 annual report
Last updated: 16/04/2013 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021
PRAC, Last updated: 12/03/2021